Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Public ClinicalTrials.gov record NCT01912274. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Open-Label, Single-arm, Two-Stage, Multicenter Trial of Pracinostat in Combination With Azacitidine in Elderly (Age 65 Years or Older) Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Study identification
- NCT ID
- NCT01912274
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Helsinn Healthcare SA
- Industry
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- Pracinostat Drug
- Azacitidine Drug
Drug
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 23, 2013
- Primary completion
- Nov 7, 2016
- Completion
- Nov 7, 2016
- Last update posted
- Feb 8, 2021
2013 – 2016
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Comprehensive Cancer Ctr | Duarte | California | 91010 | — |
| USC Norrris Cancer Center | Los Angeles | California | 90033 | — |
| Bay Area Cancer Research Group | Pleasant Hill | California | 94523 | — |
| Stanford University School of Medicine | Stanford | California | 94305-5821 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Inidana Univ Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Mercy Medical Research Center | Springfield | Missouri | 65807 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198-7680 | — |
| Cooper Hospital | Camden | New Jersey | 08103 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Medical College of South Carolina-Hollings Cancer Ctr | Charleston | South Carolina | 29425 | — |
| UT Southwestern Medical Center at Dallas | Dallas | Texas | 75390-9179 | — |
| MD Anderson | Houston | Texas | 77030 | — |
| Medical College of Wisconsin-Froedtert Cancer Center | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01912274, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01912274 live on ClinicalTrials.gov.